KARS Mutations Impair Brain Myelination by Inducing Oligodendrocyte Deficiency: One Potential Mechanism and Improvement by Melatonin
Journal of Pineal Research · 2024-08 · 76 (5)
DOI: 10.1111/jpi.12998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, 2024-08. Verfasst von Lijia Yu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Melatonin, Myelin Sheath, Oligodendroglia, Lysine-tRNA Ligase. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This work was supported by the National Natural Science Foundation of China (82271227), the National Natural Science Foundation of China (82301339), the Nation….
Abstract (Originalsprache)
It is very crucial to investigate key molecules that are involved in myelination to gain an understanding of brain development and injury. We have reported for the first time that pathogenic variants p.R477H and p.P505S in KARS , which encodes lysyl‐tRNA synthetase (LysRS), cause leukoencephalopathy with progressive cognitive impairment in humans. The role and action mechanisms of KARS in brain myelination during development are unknown. Here, we first generated Kars knock‐in mouse models through the CRISPR‐Cas9 system. Kars knock‐in mice displayed significant cognitive deficits. These mice also showed significantly reduced myelin density and content, as well as significantly decreased myelin thickness during development. In addition, Kars mutations significantly induced oligodendrocyte differentiation arrest and reduction in the brain white matter of mice. Mechanically, oligodendrocytes’ significantly imbalanced expression of differentiation regulators and increased capase‐3‐mediated apoptosis were observed in the brain white matter of Kars knock‐in mice. Furthermore, Kars mutations significantly reduced the aminoacylation and steady‐state level of mitochondrial tRNA Lys and decreased the protein expression of subunits of oxidative phosphorylation complexes in the brain white matter. Kars knock‐in mice showed decreased activity of complex IV and significantly reduced ATP production and increased reactive oxygen species in the brain white matter. Significantly increased percentages of abnormal mitochondria and mitochondrion area were observed in the oligodendrocytes of Kars knock‐in mouse brain. Finally, melatonin (a mitochondrion protectant) significantly attenuated mitochondrion and oligodendrocyte deficiency in the brain white matter of Kars R504H/P532S mice. The mice treated with melatonin also showed significantly restored myelination and cognitive function. Our study first establishes Kars knock‐in mammal models of leukoencephalopathy and cognitive impairment and indicates important roles of KARS in the regulation of mitochondria, oligodendrocyte differentiation and survival, and myelination during brain development and application prospects of melatonin in KARS (or even aaRS) ‐ related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Neurology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China.
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology Chinese Academy of Sciences, University of Chinese Academy of Sciences,…
- Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopaedic Department of Tongji Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
- Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China.
Förderung
- This work was supported by the National Natural Science Foundation of China (82271227), the National Natural Science Foundation of China (82301339), the Nation…
Zitieren
APA
Yu, L., Chen, Z., Zhou, X., Teng, F., Bai, Q. R., Li, L., Li, Y., Liu, Y., Zeng, Q., Wang, Y., Wang, M., Xu, Y., Tang, X., & Wang, X. (2024). KARS Mutations Impair Brain Myelination by Inducing Oligodendrocyte Deficiency: One Potential Mechanism and Improvement by Melatonin. Journal of Pineal Research, 76(5). https://doi.org/10.1111/jpi.12998
Vancouver
Yu L, Chen Z, Zhou X, Teng F, Bai QR, Li L, et al. KARS Mutations Impair Brain Myelination by Inducing Oligodendrocyte Deficiency: One Potential Mechanism and Improvement by Melatonin. Journal of Pineal Research. 2024;76(5). doi:10.1111/jpi.12998
BibTeX
@article{Yu2024,
author = {Yu, Lijia and Chen, Zhilin and Zhou, Xiaolong and Teng, Fei and Bai, Qing-Ran and Li, Lixi and Li, Yunhong and Liu, Ying and Zeng, Qiyu and Wang, Yong and Wang, Meihua and Xu, Yaling and Tang, Xiaohui and Wang, Xijin},
title = {KARS Mutations Impair Brain Myelination by Inducing Oligodendrocyte Deficiency: One Potential Mechanism and Improvement by Melatonin},
journal = {Journal of Pineal Research},
year = {2024},
volume = {76},
number = {5},
doi = {10.1111/jpi.12998}
}
EUVIMED